It's also worth noting that in 2005, the FDA rejected a Public Citizen petition to ban Meridia saying the overall risk-benefit profile of the drug supports keeping it on the market.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.